Business Health Assessment
Available now. A preliminary self-reported view that identifies where the main risks may lie, what matters most and which evidence gaps deserve attention.
CENARA is the independent assurance layer between the problem and the technology decision. We built CENARA because important decisions deserve more than opinions, product demonstrations and generic scoring. Our role is to establish what matters, test the evidence, keep uncertainty visible and help organisations make decisions they can explain and defend. We support important decisions across CX, compliance, AI and technology, from defining the problem and assessing what you already have to comparing options and validating the final decision. Where required, we also test commercial assumptions, whole-life cost and whether an existing decision remains valid as circumstances change. Our work brings together senior experience across customer experience, technology, operations, compliance, governance and AI, with specialist expertise matched to the decision. CENARA One keeps the requirements, evidence, approvals and rationale connected throughout.
Complex technology decisions do not all start in the same place. You may be framing a new decision, testing what you already own, assessing AI or control risk, running a vendor selection, normalising commercial responses or revisiting a decision as circumstances change. CENARA applies the same evidence standards and decision record to each situation.
We establish the decision, outcomes, stakeholders, constraints, evidence sources and review boundary before options are scored. Discovery is tailored to the organisation and the decision so effort is focused on what materially needs to be tested.
Useful when the problem is unclear, stakeholders disagree, evidence is fragmented or a significant decision needs a structured starting point.
We assess products, editions, licences, utilisation, feature adoption, cost, overlap, integrations, support, compliance value, renewal and end-of-life exposure. The result shows where to retain, optimise, remediate, consolidate, retire or replace, before new spend is assumed.
Useful when renewals are approaching, utilisation is unclear, costs are rising, platforms overlap or a replacement case needs to be tested against optimisation.
We test AI, automation and regulated technology against the business outcome, control environment, operating risk, evidence, governance and readiness required to use it safely. Potential concerns remain distinct from evidence-supported findings, and AI-generated analysis is never treated as automatic approval.
Useful when AI or automation is being proposed, control maturity is uncertain, compliance exposure matters or an existing technology control needs independent testing.
Where change is justified, CENARA converts validated needs into technology-neutral requirements and compares credible options at exact product, edition, version, deployment and regional scope. Supplier claims, cited evidence, prerequisites, limitations, mandatory gaps and commercial assumptions remain visible through RFI/RFP, clarification, demonstration and decision.
Useful when running a formal selection, challenging a preferred supplier, comparing shortlists, normalising commercial responses or preparing an auditable recommendation.
Clarify the outcomes, requirements, constraints and risks before products or suppliers influence the conversation. This keeps the evaluation focused on your needs rather than the market.
Agree what is essential, what is desirable and where trade-offs are acceptable. Weight those priorities so the assessment reflects what matters most to your organisation.
Test claims and assumptions against the available evidence. Keep gaps, limitations and confidence visible so the recommendation rests on what can be supported.
Assess viable options against the same requirements, evidence standards and priorities. This makes trade-offs clear and keeps every option subject to the same rules.
Preserve the evidence, trade-offs, assumptions and rationale behind the recommendation so the decision can be explained, challenged and revisited later.
Use the lightest level of assurance the decision justifies
Not every decision needs a full engagement. CENARA starts with the smallest useful intervention and only recommends deeper work where the evidence, risk and reversibility of the decision justify it.
Available now. A preliminary self-reported view that identifies where the main risks may lie, what matters most and which evidence gaps deserve attention.
Where the decision warrants deeper testing, Discovery Review tests the evidence, challenges assumptions and turns uncertainty into prioritised findings and a clear next step.
Use the tested evidence to select, optimise, govern or stop an initiative with a clear record of why the decision was made and what it depends on.
Keep technical suitability separate from the commercial position. CENARA normalises material cost categories, pricing scope, assumptions, exclusions and confidence so unknown costs do not quietly become zero and a commercial relationship cannot improve a technical score.
Important decisions age. CENARA can revisit the frozen decision record when requirements, regulation, product versions, vendor evidence, commercial conditions or implementation outcomes change, distinguishing why the original decision was justified then from whether the same decision is still supportable now.
CENARA One connects the Business Health Assessment, Discovery Review, current-technology analysis, weighted requirements, evidence, product intelligence and decision rationale in one structured workspace. It keeps what you need, what the evidence shows, what was compared and why the final decision was made in one traceable record.